Zhenyu Mu

3.1k total citations
17 papers, 806 citations indexed

About

Zhenyu Mu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Zhenyu Mu has authored 17 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Zhenyu Mu's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). Zhenyu Mu is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (5 papers) and CAR-T cell therapy research (4 papers). Zhenyu Mu collaborates with scholars based in United States, China and Italy. Zhenyu Mu's co-authors include Dawen Yu, John S. Munger, Zhicheng Zhao, Vladimir Jurukovski, Xiaozhong Xiong, Branka Dabovic, Zhiwei Yang, Joanne Sung, Jianda Yuan and Jedd D. Wolchok and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Cancer Research.

In The Last Decade

Zhenyu Mu

15 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenyu Mu United States 9 372 356 283 186 78 17 806
JD Cashman Canada 15 389 1.0× 353 1.0× 397 1.4× 94 0.5× 130 1.7× 24 1.5k
Manuel Selg Sweden 4 304 0.8× 500 1.4× 257 0.9× 225 1.2× 38 0.5× 6 1.1k
Jens Wanzeck United States 6 396 1.1× 370 1.0× 518 1.8× 70 0.4× 48 0.6× 7 1.0k
Motohiro Hashiyama Japan 12 414 1.1× 249 0.7× 178 0.6× 101 0.5× 97 1.2× 13 766
Jessica Tsui United States 9 333 0.9× 491 1.4× 343 1.2× 88 0.5× 39 0.5× 15 987
R Kay Canada 8 366 1.0× 378 1.1× 232 0.8× 81 0.4× 93 1.2× 10 994
Marina Strasly Italy 8 488 1.3× 203 0.6× 207 0.7× 337 1.8× 39 0.5× 10 907
Brandon Harder United States 14 372 1.0× 634 1.8× 332 1.2× 166 0.9× 180 2.3× 19 1.4k
Amédée Renand France 18 257 0.7× 416 1.2× 140 0.5× 146 0.8× 34 0.4× 22 997
Carla Danussi Italy 11 412 1.1× 125 0.4× 200 0.7× 115 0.6× 83 1.1× 15 709

Countries citing papers authored by Zhenyu Mu

Since Specialization
Citations

This map shows the geographic impact of Zhenyu Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Mu more than expected).

Fields of papers citing papers by Zhenyu Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Mu. The network helps show where Zhenyu Mu may publish in the future.

Co-authorship network of co-authors of Zhenyu Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyu Mu. A scholar is included among the top collaborators of Zhenyu Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyu Mu. Zhenyu Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Xiaolei, et al.. (2025). Integrated gut microbiota and serum metabolomics reveal glyphosate-induced hepatic injury in mice. Human & Experimental Toxicology. 44. 3550345117–3550345117.
2.
Yang, Xiaolei, et al.. (2025). The role of cholesterol in glyphosate-induced reproductive toxicity: A mechanistic study involving the liver-testis axis. Ecotoxicology and Environmental Safety. 305. 119249–119249.
3.
Zhu, Z. A., Jinghong Hu, Jiaqi Wu, et al.. (2024). Integrated microbiomic and metabolomic dynamics of Yi traditional fermented liquor. Food Chemistry X. 24. 102016–102016. 4 indexed citations
4.
Funt, Samuel A., Zhenyu Mu, C Cipolla, et al.. (2017). Evaluation of monocytic myeloid-derived suppressor cell (M-MDSC) frequency in patients with metastatic urothelial carcinoma (mUC).. Journal of Clinical Oncology. 35(6_suppl). 356–356. 1 indexed citations
5.
Paolillo, Carmela, Zhenyu Mu, Laura Austin, et al.. (2016). Abstract P2-02-11: Detection of activating estrogen receptor 1 (ESR1) mutation on single circulating tumor cells from metastatic breast cancer patients. Cancer Research. 76(4_Supplement). P2–2. 1 indexed citations
6.
Autio, Karen A., Phillip Wong, Jianda Yuan, et al.. (2015). Presence of myeloid-derived suppressor cells (MDSC) in patients with metastatic castration-sensitive and castration-resistant prostate cancer.. Journal of Clinical Oncology. 33(7_suppl). 222–222. 1 indexed citations
8.
Kitano, Shigehisa, Takemasa Tsuji, Daniel Hirschhorn-Cymerman, et al.. (2013). Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients. Cancer Immunology Research. 1(4). 235–244. 96 indexed citations
9.
Yuan, Jianda, Geoffrey Y. Ku, Matthew Adamow, et al.. (2013). Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma. Journal for ImmunoTherapy of Cancer. 1(1). 20–20. 38 indexed citations
10.
Gyorki, David, Jianda Yuan, Zhenyu Mu, et al.. (2013). Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma. Annals of Surgical Oncology. 20(9). 3106–3111. 42 indexed citations
11.
Gyorki, David, Jianda Yuan, Zhenyu Mu, et al.. (2012). Surgery for patients receiving ipilimumab: Safety profile and immunological insights.. Journal of Clinical Oncology. 30(15_suppl). 8583–8583. 1 indexed citations
12.
Yuan, Jianda, David B. Page, Geoffrey Y. Ku, et al.. (2010). Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.. PubMed. 10. 1–1. 36 indexed citations
13.
Ginsberg, Brian, Humilidad F. Gallardo, Teresa Rasalan, et al.. (2010). Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection. Clinical Cancer Research. 16(15). 4057–4065. 39 indexed citations
14.
Yuan, Jianda, Geoffrey Y. Ku, Humilidad F. Gallardo, et al.. (2009). Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.. PubMed. 9. 5–5. 62 indexed citations
15.
Mu, Zhenyu, et al.. (2008). TGFβ1 and TGFβ3 are partially redundant effectors in brain vascular morphogenesis. Mechanisms of Development. 125(5-6). 508–516. 54 indexed citations
16.
Mu, Zhenyu, Zhicheng Zhao, Dawen Yu, et al.. (2008). Mice that lack activity of αvβ6- and αvβ8-integrins reproduce the abnormalities ofTgfb1- andTgfb3-null mice. Journal of Cell Science. 122(2). 227–232. 177 indexed citations
17.
Yang, Zhiwei, Zhenyu Mu, Branka Dabovic, et al.. (2007). Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice. The Journal of Cell Biology. 176(6). 787–793. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026